The Christine Mohrmann stipendium is awarded yearly to 10 promising female PhD candidates from the different faculties of the Radboud University in Nijmegen.
The goal of the stipendium is to enable junior female scientists to perform research abroad and to encourage them to pursue a scientific career in academia.
Karlien Mul from the department of Neurology, theme Disorders of movement, has been awarded the Christine Mohrmann stipendium of €5000,- in order to visit the National Institute of Health, USA.
Karlien studies Facioscapulohumeral muscular dystrophy (FSHD), an incurable hereditary muscle disease, for which at the moment various therapies are under development that will be tested for efficacy within a few years. In a rare, slowly progressive disease such as FSHD, setting up drug trials is a challenge. Karlien Mul investigates how drug research at FSHD can be set up. She uses the stipend to visit a research group at the National Institutes of Health who have experience with such research.
(Karlien Mul, second person from the right)
Related news items
Radboudumc Master Prize for Mark van Goor18 June 2019
Mark van Goor, theme Renal disorders, received the Radboudumc Master Prize for his MSc thesis entitled “High-resolution structure of the renal calcium channel TRPV5 revealed with cryo-EM”, which was based on his internship at the lab of Prof. Yifan Cheng, USA.read more
Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies18 June 2019
Exome sequencing may provide a genetic diagnosis in a significant number of patients in a single genetic test. Alexander Hoischen and Mihai Netea, theme Infectious diseases and global health, and colleagues, published their results in Genome Medicine.read more
Lowering cholesterol is not enough to reduce hyperactivity of the immune system14 June 2019
In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.read more